Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recent advances in estrogen receptor modulators.

Brad R Henke¹, Dennis Heyer

¹GlaxoSmithKline Inc, Metabolic and Viral Diseases Drug Discovery, Research Triangle Park, PO Box 13398, NC 27705, USA. brad.r.henke@gsk.com

Current Opinion in Drug Discovery & Development

|July 19, 2005

Summary

New estrogen receptor modulators offer improved treatments for menopause and breast cancer, addressing side effects of current drugs. Research focuses on novel ligands targeting estrogen receptor subtypes for better therapeutic outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk.

PloS one·2023

Same author

Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.

Journal of medicinal chemistry·2021

Same author

Inhibitor Mimetic Mutations in the <i>Pseudomonas aeruginosa</i> PqsE Enzyme Reveal a Protein-Protein Interaction with the Quorum-Sensing Receptor RhlR That Is Vital for Virulence Factor Production.

ACS chemical biology·2021

Same author

A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.

Molecular genetics and metabolism·2021

Same author

Mechanism underlying autoinducer recognition in the <i>Vibrio cholerae</i> DPO-VqmA quorum-sensing pathway.

The Journal of biological chemistry·2020

Same author

Discovery of PqsE Thioesterase Inhibitors for <i>Pseudomonas aeruginosa</i> Using DNA-Encoded Small Molecule Library Screening.

ACS chemical biology·2019

Area of Science:

Endocrinology
Pharmacology
Oncology

Background:

Estrogen modulation effectively treats menopause symptoms and breast cancer.
Current estrogen receptor drugs have significant side effects.
Understanding estrogen receptor signaling drives new drug discovery.

Purpose of the Study:

To review recent clinical and preclinical developments in novel estrogen receptor modulators.
To highlight new ligand classes targeting estrogen receptor subtypes.

Main Methods:

Review of recent clinical and preclinical studies.
Analysis of novel chemical compounds targeting estrogen receptor subtypes.

Main Results:

Emerging novel classes of ligands demonstrate potential for improved estrogen modulation.

Related Experiment Videos

Advances in understanding estrogen receptor signaling facilitate targeted drug development.

Conclusions:

Novel estrogen receptor ligands are being developed with improved therapeutic profiles.
Targeted modulation of estrogen receptor subtypes offers promising therapeutic strategies.